| __timestamp | Gilead Sciences, Inc. | United Therapeutics Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 2854000000 | 242549000 |
| Thursday, January 1, 2015 | 3014000000 | 245098000 |
| Friday, January 1, 2016 | 5098000000 | 147600000 |
| Sunday, January 1, 2017 | 3734000000 | 264600000 |
| Monday, January 1, 2018 | 5018000000 | 357900000 |
| Tuesday, January 1, 2019 | 9106000000 | 1182600000 |
| Wednesday, January 1, 2020 | 5039000000 | 357700000 |
| Friday, January 1, 2021 | 5363000000 | 540100000 |
| Saturday, January 1, 2022 | 4977000000 | 322900000 |
| Sunday, January 1, 2023 | 6923000000 | 408000000 |
| Monday, January 1, 2024 | 5907000000 |
Data in motion
In the competitive world of biotechnology, innovation is the lifeblood of success. Gilead Sciences, Inc. and United Therapeutics Corporation are two titans in this arena, each with a distinct approach to research and development (R&D) investment. From 2014 to 2023, Gilead Sciences consistently outpaced United Therapeutics in R&D spending, with an average annual investment nearly 12 times greater. Notably, in 2019, Gilead's R&D expenses surged to a peak, marking a 220% increase from 2014. Meanwhile, United Therapeutics showed a steady, albeit smaller, growth in R&D investment, peaking in 2019 with a 388% increase from its 2014 figures. This disparity highlights Gilead's aggressive strategy in pioneering new treatments, while United Therapeutics maintains a more measured approach. As the biotech landscape evolves, these investment patterns may shape the future of medical breakthroughs.
AstraZeneca PLC or United Therapeutics Corporation: Who Invests More in Innovation?
Comparing Innovation Spending: Pfizer Inc. and Gilead Sciences, Inc.
Gilead Sciences, Inc. vs GSK plc: Strategic Focus on R&D Spending
Comparing Innovation Spending: Gilead Sciences, Inc. and Alkermes plc
Gilead Sciences, Inc. vs Geron Corporation: Strategic Focus on R&D Spending
Analyzing R&D Budgets: Gilead Sciences, Inc. vs Amphastar Pharmaceuticals, Inc.
R&D Insights: How argenx SE and United Therapeutics Corporation Allocate Funds
R&D Insights: How United Therapeutics Corporation and Intra-Cellular Therapies, Inc. Allocate Funds
R&D Insights: How United Therapeutics Corporation and MannKind Corporation Allocate Funds
R&D Spending Showdown: United Therapeutics Corporation vs Iovance Biotherapeutics, Inc.
United Therapeutics Corporation vs Supernus Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Comparing Innovation Spending: United Therapeutics Corporation and Amphastar Pharmaceuticals, Inc.